Two Sigma Securities’s Kiora Pharmaceuticals KPRX Stock Holding History

Two Sigma Securities’s Portfolio KPRX Stock Details KPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.2K	Buy	+12,019	New	+$25.4K	﹤0.01%	1356
2023 Q3	–	Sell	-1,370	Closed	-$7.93K	–	3230
2023 Q2	$7.93K	Buy	+1,370	New	+$28.7K	﹤0.01%	2623
2019 Q3	–	Sell	-8	Closed	-$10K	–	2267
2019 Q2	$10K	Buy	+8	New	+$11.8K	﹤0.01%	1991
2018 Q4	–	Sell	-10	Closed	-$17K	–	2520
2018 Q3	$17K	Buy	+10	New	+$26.9K	﹤0.01%	2460
2018 Q2	–	Sell	-2	Closed	-$5K	–	2843
2018 Q1	$5K	Sell	2 -4	-67%	-$17.3K	﹤0.01%	2624
2017 Q4	$33K	Hold	6	–	–	﹤0.01%	1584
2017 Q3	$37K	Buy	+6	New	+$38.2K	﹤0.01%	771
2017 Q2	–	Sell	-2	Closed	-$26K	–	1031
2017 Q1	$26K	Buy	+2	New	+$22.4K	0.01%	837

Other funds holding KPRX

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Securities's KPRX Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Kiora Pharmaceuticals (KPRX) in Q1 2026: 12,019 shares worth $23.2K. The stake represents ﹤0.01% of the portfolio and ranks #1356 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in KPRX as recently as Q2 2023.

Two Sigma Securities first reported a position in KPRX in Q1 2017 and has held it in 8 quarters since. The position peaked at $37K in Q3 2017. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.

Two Sigma Securities held 12,019 shares of Kiora Pharmaceuticals worth $23.2K as of Q1 2026.
Kiora Pharmaceuticals was a new Two Sigma Securities position in Q1 2026.
Kiora Pharmaceuticals made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1356 holding.
Two Sigma Securities first reported a position in Kiora Pharmaceuticals in Q1 2017 and has held it in 8 quarters since.
Two Sigma Securities's Kiora Pharmaceuticals position peaked at $37K in Q3 2017.
18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.